2015
DOI: 10.1161/hypertensionaha.114.04488
|View full text |Cite
|
Sign up to set email alerts
|

Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
152
0
5

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 186 publications
(160 citation statements)
references
References 83 publications
3
152
0
5
Order By: Relevance
“…These findings are consistent with clinical studies demonstrating that besides the classical use of MR antagonists for treating hypertension, pharmacological blockade of MR was also beneficial for patients suffering from other inflammatory and fibrotic diseases (Jaisser and Farman, 2016). The mechanisms mediating pathological MR activation include activation of the NF-B pathway and oxidative stress as well as upregulation of MR-targets including pro-fibrotic genes (Bauersachs et al, 2015).…”
Section: Introductionsupporting
confidence: 85%
“…These findings are consistent with clinical studies demonstrating that besides the classical use of MR antagonists for treating hypertension, pharmacological blockade of MR was also beneficial for patients suffering from other inflammatory and fibrotic diseases (Jaisser and Farman, 2016). The mechanisms mediating pathological MR activation include activation of the NF-B pathway and oxidative stress as well as upregulation of MR-targets including pro-fibrotic genes (Bauersachs et al, 2015).…”
Section: Introductionsupporting
confidence: 85%
“…58 MR is, therefore, a key therapeutic target for cardiac and renal target-organ damage in hypertension and may prevent diastolic dysfunction and heart failure development. 59,60 Indeed, MR knockout prevents development of diet-induced diastolic dysfunction. 61 Interestingly, some effects of aldosterone seem to involve angiotensin type 1a receptors.…”
Section: Mineralocorticoid Receptors In the Regulation Of Oxidative Smentioning
confidence: 99%
“…53 MR activation leads to an upregulation of proinflammatory cytokines and profibrotic proteins, such as transforming growth factor β or plasminogen activator inhibitor 1.…”
Section: Doca/salt-induced Kidney Injury Is Independent From Endothelmentioning
confidence: 99%